Dermatology is a high-volume, procedure-intensive medical specialty. In this field, the difference between CPT codes depends on centimeters, techniques, or tissue types. Successful dermatology billing requires absolute precision because a biopsy is never just a biopsy. Instead, your chosen code depends entirely on the method and the specific body site.
Furthermore, lesion removals are either destructions or excisions depending on the technique used. This sharp distinction carries significant financial and compliance implications. If you master these clinical details, you will capture the full revenue your hard work deserves. Conversely, missing these details consistently means you leave money on the table or flag your practice for a coding audit.
This comprehensive guide covers high-volume dermatology codes for 2026. We will outline the critical clinical distinctions that determine code selection. Additionally, we will review the medical necessity documentation standards and explore the denial patterns that most frequently disrupt dermatology practices.
Skin Biopsy Codes: Why the Method Matters
The current skin biopsy codes reflect the precise technique used rather than the tissue layer removed. This system eliminates historical ambiguity. However, it also creates rigid coding requirements because your operative notes must explicitly document the specific biopsy method.
Shave Removal (11102–11107)
Providers use shave removal when a blade horizontally removes a lesion. This technique applies to superficial lesions that do not extend deep into the dermal layer:
11102: Tangential biopsy of skin (shave); single or first lesion
11103: Tangential biopsy of skin (shave); each separate or additional lesion (add-on code)
Punch Biopsy (11104–11105)
A punch biopsy requires a sharp circular blade to retrieve a cylindrical core of tissue. This method intentionally extends deep into the dermis or subcutaneous space:
11104: Punch biopsy of skin; single or first lesion
11105: Punch biopsy of skin; each separate or additional lesion (add-on code)
Incisional Biopsy (11106–11107)
An incisional biopsy requires a scalpel to slice out a deep wedge of tissue. This approach must include a representative portion of the lesion’s base:
11106: Incisional biopsy of skin; single or first lesion
11107: Incisional biopsy of skin; each separate or additional lesion (add-on code)
Documentation Standard: Your operative record must clearly state the technique. Use exact terms like “shave biopsy,” “punch biopsy,” or “incisional biopsy.” Brief notes that only state “biopsy performed” fail to provide adequate specificity. Consequently, payers will either process the claim at the lowest-value code or deny it completely.
Destruction of Benign vs. Malignant Lesions
Coders utilize destruction codes (17000–17286) when a provider removes a lesion via physical or chemical means. This includes cryotherapy, electrodesiccation, laser ablation, or electrosurgery without submitting a specimen to pathology.
Destruction of Benign or Premalignant Lesions (17000–17004)
17000: Destruction of benign or premalignant lesion (e.g., actinic keratosis); first lesion
17003: Destruction of benign or premalignant lesion; each additional lesion, 2nd through 14th (add-on code)
17004: Destruction of premalignant lesions; 15 or more lesions
You must report codes 17000 and 17003 together for 2 to 14 lesions. However, if the provider destroys 15 or more lesions, bill code 17004 alone. Never combine code 17000 with multiple 17003 add-ons for large sessions. This mistake represents a highly common error in dermatology billing workflows.
Destruction of Malignant Lesions (17260–17286)
Malignant destruction codes depend directly on lesion size and anatomical location. These codes require a confirmed malignant diagnosis alongside the exact measured size of the lesion:
17260–17266: Destruction, malignant lesion; trunk, arms, or legs (sorted by size)
17270–17276: Destruction, malignant lesion; scalp, neck, hands, feet, or genitalia (sorted by size)
17280–17286: Destruction, malignant lesion; face, ears, eyelids, nose, or lips (sorted by size)
Excision of Benign and Malignant Lesions
Excision codes differ from destruction codes because the provider always sends the tissue specimen to pathology. Coders select these codes based on the location and the total excised diameter. This diameter must include the lesion plus the margins. Simple closures are included, but you can bill intermediate or complex repairs separately.
Excision of Benign Lesions (11400–11471)
Benign excision codes depend on the body site and the total excised diameter. This diameter represents the actual margin measurement removed during surgery, not the pre-surgical lesion size.
11400–11406: Trunk, arms, or legs (sorted by excised diameter in centimeters)
11420–11426: Scalp, neck, hands, feet, or genitalia
11440–11446: Face, ears, eyelids, nose, lips, or mucous membranes
Excision of Malignant Lesions (11600–11646)
Malignant excision codes follow the same site-and-size structure as benign codes. However, they yield higher reimbursement and require a confirmed or clinically suspected malignant diagnosis. If pathology results return benign for a clinically malignant lesion, the malignant excision code stands. You must code the clinical impression recorded at the time of service.
Navigating Mohs Micrographic Surgery Claims
Mohs surgery billing (17311–17315) depends on the number of stages and the tissue blocks examined per stage. It is a highly scrutinized code family because it is incredibly structured.
17311: Mohs surgery; head, neck, hands, feet, or genitalia, first stage, up to 5 blocks
17312: Each additional stage (head, neck, hands, feet, or genitalia), up to 5 blocks (add-on code)
17313: Mohs surgery; trunk, arms, or legs, first stage, up to 5 blocks
17314: Each additional stage (trunk, arms, or legs), up to 5 blocks (add-on code)
17315: Each additional block beyond 5 blocks in any single stage (add-on code)
Mohs Documentation Standard: The surgeon must map and document every single stage. The chart needs a clear diagram showing the tissue orientation, the examined margins, and the pathology results. This documentation must happen before the surgeon proceeds to the next stage. Payers frequently request these maps, and weak records trigger immediate recoupment.
Cosmetic vs. Medical: The Coverage Boundary
Many dermatology procedures exist on the line between covered medical services and non-covered cosmetic treatments. Payers routinely deny claims containing cosmetic indications. This occurs even when the physical procedure matches a medically necessary service.
Covered Treatment: Excision of a congenital melanocytic nevus with documented rapid growth or atypical clinical features.
Non-Covered Treatment: Excision of a stable, completely benign nevus based solely on patient aesthetic preference.
Covered Treatment: Laser ablation for a prominent port wine stain birthmark to treat an underlying medical condition.
Non-Covered Treatment: Laser treatment for benign cosmetic telangiectasias without any documented medical symptoms.
Always document the medical indication, symptoms, functional impairment, or risk of malignant transformation. If a procedure is cosmetic, collect the full payment from the patient upfront and do not bill insurance.
Five Critical Dermatology Billing Denials
1. Wrong Biopsy Code for the Method Used
Billing a punch code when the note documents a shave technique triggers immediate rejections. The selected code must match the text exactly. Therefore, your team should audit biopsy claims quarterly to verify your documentation matches the codes.
2. Failure to Use 17004 for Massive Destructions
Billing code 17000 plus thirteen 17003 add-on codes for 15 lesions is a major error. Code 17004 is the correct option and pays at a higher rate. Because most practice software cannot auto-switch this code, your team must track the threshold.
3. Mohs Stage Documentation Deficiencies
Payers issue rejections when your operative record lacks detailed stage maps or pathology results. Mohs claims require comprehensive, surgeon-level details. Brief procedure notes fail to satisfy commercial insurance reviewers.
4. Cosmetic Denials on Medical Procedures
This issue occurs when you bill a medically necessary procedure with an insufficient diagnosis code. To prevent this error, link the clear clinical indication to your primary diagnosis on the claim form.
5. Excision Size Mismatches
Billing a large excision code when the note records a small excised diameter creates compliance risks. Your notes must state the exact diameter including margins. For example, a “0.8 cm lesion removed” supports code 11401, not 11402.
Streamlining Your Dermatology Billing Processes
Practices maximize revenue when they code precisely, document thoroughly, and review records regularly. Running a regular chart audit focused on biopsy methods, excision sizes, and destruction codes protects your cash flow. These reviews typically uncover $20,000 to $60,000 in annualized undercoding. Simultaneously, they eliminate equivalent risks from overcoding recoupments.
The specialized dermatology billing team at Right On Time Medical Billing manages code selection and document reviews. We handle Mohs claims and denial management for practices across all 50 states. Contact us today to schedule your free dermatology billing accuracy assessment.
Free Dermatology Billing Assessment
Precision procedure coding for biopsies, Mohs, destructions, and excisions, across all payers.
